Welcome to our dedicated page for Apollo Endosurge news (Ticker: APEN), a resource for investors and traders seeking the latest updates and insights on Apollo Endosurge stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Apollo Endosurge's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Apollo Endosurge's position in the market.
Apollo Endosurgery (NASDAQ:APEN) will present at the LD 500 investor conference on September 2, 2020, at 11:40 AM ET. CEO Todd Newton and CFO Stefanie Cavanaugh will address a live virtual audience and conduct investor meetings throughout the day. Interested participants can register at LD Micro. Apollo specializes in less invasive medical devices for gastrointestinal and bariatric procedures, with products available in over 75 countries, including the OverStitch™ and ORBERA® systems. For more details, visit Apollo Endosurgery.